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Open access under the ElsThe amygdala, medial hypothalamus, dorsal periaqueductal gray (dPAG), superior and inferior colliculus
together constitutes the encephalic aversion system which has been considered the main neural sub-
strate for the integration of unconditioned aversive behavioral states. Within the amygdala the basolat-
eral nucleus (BLA) is thought to act as a ﬁlter for innate and learned aversive information to higher
structures, whereas the central nucleus (CeA) is considered the main output for the expression of fear
reactions through projections to limbic and brainstem regions. Although neurokinin (NK) receptors are
abundant in the amygdala, their role in the processing and expression of fear is yet unclear. In this study,
we examined the role of SP/NK1 receptor system of the CeA and BLA on the expression of defensive
responses elaborated by Wistar rats submitted to elevated plus maze (EPM) and to electrical stimulation
(ES) of the dPAG. For EPM test, cannulae were implanted in the CeA and BLA for injections of substance P
(SP – 10 and 100 pmol/0.2 lL) and spantide (SPA – 10, 100 and 500 pmol/0.2 lL). For ES of dPAG, aversive
thresholds for freezing and escape responses as well as post-stimulation freezing (PSF) were measured in
rats treated with PBS and SPA (100 pmol/0.2 lL) in CeA. Injections of SP into the CeA, but not the BLA,
produced anxiogenic-like effects in the EPM test. SPA injected into the CeA had no effect on the explor-
atory behavior of rats submitted to the EPM but blocked the effects of SP. The duration of dPAG-PSF was
also reduced signiﬁcantly following injection of SPA in CeA but had no effect on thresholds for freezing
and escape responses. The EPM gives the animal a control over its environment i.e. the option to choose
or not to enter into the open arm and dPAG-PSF is thought to reﬂect a period when the animal evaluates
the signiﬁcance of dPAG-evoked aversion once the unconditioned responses of freezing and escape were
elicited. The data indicate that SP may be involved in mediating responses of the animal in only certain
types of aversive behavior and suggests a differential participation of the NK1 receptors in the processing
of distinct types of fear in the amygdala.
 2013 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
The amygdaloid complex, medial hypothalamus, periaqueduc-
tal gray (PAG) together with the deep layers of the superior and
inferior colliculi constitute the encephalic aversion system (EAS),
which has been considered the main neural substrate for the inte-
gration of unconditioned aversive states such as anxiety and fear
(Canteras, 2002; Comoli, Ribeiro-Barbosa, & Canteras, 2003; Graeff,substance P; SPA, spantide;
eral nucleus of the amygdala;
imulation; PSF, post-freezing
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evier OA license. 1990; Olds & Olds, 1963; Strauss, Maisonnette, Coimbra, & Zang-
rossi, 2003; Sullivan, Apergis, Gorman, & LeDoux, 2003).
The PAG, particularly its dorsal half (dPAG), is considered as a
mesencephalic output of this system (Canteras, Chiavegatto, Valle,
& Swanson, 1997; Canteras & Goto, 1999). More speciﬁcally, the
dPAG is critically involved in the production of unconditioned
fear. It has been observed that electrical or chemical stimulation
of this region induces freezing and escape responses, accompa-
nied by cardiovascular and neurovegetative changes, that are sim-
ilar to those observed in markedly aversive situations such as
confrontation with predators (Bandler & Depaulis, 1991; Brandao,
Anseloni, Pandossio, De Araujo, & Castilho, 1999; Olds & Olds,
1962). Indeed, the response to stimulation of the dPAG in animals
has been effectively used as a model of panic attacks in humans
(Graeff, 1990; Graeff & Zangrossi, 2002; Jenck, Moreau, & Martin,
1995; Lovick, 2000; Schenberg, Bittencourt, Sudre, & Vargas,
2001).
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medial hypothalamus act upstream from this system. In particular,
the amygdala is quite extensively involved in the stimulus process-
ing and in the memory of the aversive events (Parsons & Davis,
2012). It synthesizes the stimulus input from the environment
and depending on the type of the threat, it acts with the neural
substrate of fear in the dPAG (Fanselow, 1991; Gross & Canteras,
2012; Ledoux, 1994; Zhao, Yang, Walker, & Davis, 2009). It has
been suggested that the amygdala has a critical role in the develop-
ment of panic attacks and the pathogenesis of panic disorder (Da-
vis & Whalen, 2001; Kim, Dager, & Lyoo, 2012; Phelps & LeDoux,
2005; Shekhar, Sajdyk, Gehlert, & Rainnie, 2003).
Behavioral studies have been shown that the basolateral nu-
cleus of amygdala (BLA) is involved in processing afferent informa-
tion related to innate and learned aversive situations, which
ascends to higher structures from the brainstem. In contrast, the
central nucleus (CeA) is considered the main output for the auto-
nomic and somatic components of fear reaction through projec-
tions to other limbic and brainstem regions, including the dPAG
(Davis, Rainnie, & Cassell, 1994; Ledoux, 1994; LeDoux, Cicchetti,
Xagoraris, & Romanski, 1990; LeDoux, Iwata, Cicchetti, & Reis,
1988). The excitability of the output neurons of the CeA is regu-
lated by a tonic inhibitory inﬂuence from the BLA (Nitecka &
Ben-Ari, 1987). It has also been shown that the amygdala is in-
volved in the evaluation/consolidation of recent aversive events.
Electrical stimulation (ES) of the dPAG evokes escape which is fol-
lowed, once the stimulation ceases, by a period of immobility
termed post-stimulation freezing (PSF) (Martinez, de Oliveira, &
Brandão, 2006; Vianna, Graeff, Brandao, & Landeira-Fernandez,
2001a; Vianna, Graeff, Landeira-Fernandez, & Brandao, 2001b).
The dPAG-PSF reﬂects the process of ascending aversive informa-
tion to prosencephalic centers including the amygdala via the
medial forebrain bundle, which allows the animal to evaluate the
consequences of aversive situation and aids the recognition of
threatening stimuli in fear-experienced animals (Brandao, Zanov-
eli, Ruiz-Martinez, Oliveira, & Landeira-Fernandez, 2008).
Substance P (SP) is widely distributed in the brain including the
amygdala and it is involved in the regulation of behavioral pro-
cesses such as reinforcement, learning, memory, fear and anxiety
and also in the mediation of stress responses (Chahl, 2006; Ebner,
Rupniak, Saria, & Singewald, 2004; Hasenohrl et al., 2000; Huston
& Hasenohrl, 1995). Three NK receptors have been so far identiﬁed
– NK-1, NK-2, and NK-3. Despite the fact that SP binds to all recep-
tor types, it shows higher afﬁnity to NK-1 receptor (Hokfelt, Bartfai,
& Bloom, 2003; Mantyh, 2002; Mussap, Geraghty, & Burcher, 1993;
Quartara & Maggi, 1998). Evidence for the participation of the SP/
NK1 receptor systems of the BLA on the expression of defensive re-
sponses of rats to aversive situations has been repeatedly reported
in the literature (Boyce et al., 2001; Smith et al., 1999; Zhao et al.,
2009). Nevertheless, the investigation of the SP/NK1 systems of the
CeA has received less attention. We have therefore evaluated the
role of local injections of SP and/or the spantide (SPA, a NK-1 pep-
tidergic receptor antagonist) into CeA or BLA of rats submitted to
distinct aversive situations: (1) the elevated plus maze test
(EPM), which measures defensive responses to potentially threat-
ening stimuli, and (2) ES of the dPAG procedure at the freezing
threshold (cessation of all movement apart from breathing, be-
lieved to represent evaluation of distal threat); escape threshold
(running and/or jumping, a measure of the response to proximal
threat); and PSF (which may be related to the memory of the aver-
sive stimulation of this structure). The former measures the con-
ﬂict between staying in the safety of the closed arms and the
danger of the height and openness of the open arms (Pellow, Cho-
pin, File, & Briley, 1985) and the latter represents unconditioned
panic-like reaction which is used as an animal model of panic at-
tacks (Graeff, 1990; Jenck et al., 1995; Schenberg et al., 2001).2. Materials and methods
2.1. Animals
The experiments were performed in accordance with the Brazil-
ian Society of Neuroscience and Behavior Guidelines for the Care
and Use of Laboratory Animals. The procedures were approved
by the Committee on Animal Research and Ethics (CEUA) of the
University of Sao Paulo (n 09.1.84.54.7). All efforts were made to
minimize the number and potential suffering of the animals used.
In total, 134 male Wistar rats, weighing 250–300 g, from the ani-
mal house of the Campus of Ribeirão Preto of the University of
São Paulo were housed in a temperature-controlled room
(22 ± 1 C) and maintained on a 12 h/12 h light/dark cycle (lights
on at 07:00 a.m.). Animals were kept in Plexiglas walled cages
and given free access to food and water throughout the experi-
ment. The rats were randomly assigned to one of two surgery
groups: BLA or CeA. For the CeA group half of the animals were ex-
posed to the EPM test and half were submitted to ES of the dPAG as
described below.2.2. Surgery
The animals were anesthetized with ketamine/xylasine associa-
tion (100/7.5 mg/kg respectively, i.p., Agener União, Embu-Guaçu,
SP, Brazil) and ﬁxed in a stereotaxic frame (David Kopf, Tujunga,
CA). The upper incisor bar was set 3.3 mm below the interaural
line, such that the skull was horizontal between bregma and lamb-
da. A unilateral guide-cannula was implanted over the right BLA or
CeA. Substantial evidence indicates hemisphere-related differences
in emotional behavior. The right amygdala was chosen because the
right hemisphere is specialized in emotional behavior, particularly
negative affect, compared with the left hemisphere (Adamec,
Burton, Shallow, & Budgell, 1999; Michelgard et al., 2007). Accord-
ing to the atlas of Paxinos and Watson (2005) and with bregma
serving as the reference point, the coordinates were: for BLA –
antero-posterior (AP) 2.3 mm, medio-lateral (ML) 5.3 mm and dor-
so-ventral (DV) 7.6 mm; and for CeA – AP 1.9 mm; ML 4.1 mm and
DV 7.0 mm. Next, a bipolar brain electrode was implanted in the
midbrain aimed at the dPAG. The electrodes were made of two
twisted stainless steel wires, each 50 lm in diameter, insulated ex-
cept at the cross section of the tip. The electrode was introduced
with a 22 angle inclined medially with lambda serving as the ref-
erence for each plane: AP 0 mm, ML 1.9 mm and DV 5.2 mm. For all
groups, the cannulae and electrode were ﬁxed to the skull with
acrylic resin and two stainless steel anchor screws. Each guide-
cannula was sealed with a stainless steel wire to protect it from
blocking. At the end of surgery, animals received an injection of a
polyvalent veterinary antibiotic (Pentabiótico, 0.2 mL, intramuscu-
lar; Fort Dodge, Campinas, SP, Brazil) and an injection of the anti-
inﬂammatory and analgesic ﬂunixin meglumine (Banamine,
2.5 mg/kg, subcutaneous; Schering-Plough, Cotia, SP, Brazil). After-
ward, the rats were allowed 5 days to recover from the surgical
procedure. (Paxinos & Watson, 2005)3. Apparatus and procedure
3.1. Elevated plus maze
An EPM, described in detail elsewhere (Pellow et al., 1985) was
used, consisting of two open arms (50 cm  10 cm) crossed at right
angles with two closed arms of the same size. The two closed arms
were enclosed by walls 50 cm high, with the exception of the cen-
tral part of the maze (10 cm  10 cm) where the open and closed
arms crossed. The entire apparatus was elevated 50 cm above the
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high) surrounded the perimeter of the open arms. The experimen-
tal sessions were recorded by a video camera interfaced with a
monitor and a VCR in an adjacent room.
Five days after surgery, the rats were injected with SP or SPA
followed 5 min later by SP and immediately gently placed in the
central area of the EPMwith the nose facing one of the closed arms.
The rats were then allowed to freely explore the maze for 5 min.
Before the next rat was tested, the maze was cleaned with a 20%
ethanol solution. An observer trained to measure EPM parameters
subsequently scored the videotapes using the Etholog 2.2.5 (São
Paulo, Brazil) (Ottoni, 2000). We measured the number of entries
into both arms and the time spent on different parts of the maze.
An arm entry or exit was deﬁned as all four paws entering into
or exiting an arm, respectively. These data were used to calculate
the percentage of open arm entries and percentage of time spent
in the open arms. A detailed description of the use of the EPM in
this laboratory can be found elsewhere (Anseloni & Brandao,
1997; Carvalho, Moreira, Zanoveli, & Brandao, 2012).
3.2. Electrical stimulation of the dPAG
Five days after surgery, the animals were placed in a square
Plexiglas box (25  20  20 cm) in an illuminated room with a
40 W ﬂuorescent lamp (80 lux at the box ﬂoor level). The animals
were allowed a 5-min period of habituation in the enclosure at the
beginning of each session. Afterwards, the brain was electrically
stimulated by means of a sine wave stimulator (DelVecchio, Brazil).
The stimulation current was monitored by measuring the voltage
drop across a 1-kX resistor with an oscilloscope (Philips, USA).
Brain stimulation (60 Hz sine wave for 10 s) was presented at
pseudorandom intervals (30–120 s) with the current intensity
increasing by steps of 5 lA for determination of freezing and es-
cape thresholds. Freezing threshold was deﬁned as the lowest
intensity producing absence of any movement, except that related
to respiration, in two consecutive ascending series of ESs. The
intensity of current producing running (gallop) or jumping in
two successive trials was considered to be the escape threshold.
Animals with an escape threshold above 150 lA (peak-to-peak)
were removed from the experiment. In order to investigate the
behavior that persisted after escape, the animals remained in the
experimental box for another 8 min, without any stimulation, dur-
ing which the duration of the post-stimulation freezing behavior
(PSF) was recorded. At the end of this period, the rat received a
microinjection of SPA or PBS into the CeA. Five minutes later, the
aversive thresholds for freezing and escape as well as the PSF were
again determined.
3.3. Drugs
The SP and SPA (Sigma–Aldrich, Germany) were dissolved in
buffered saline solution 0.1 M (PBS) shortly before use. For the ele-
vated plus maze (EPM) test, the exploratory behavior was assessed
in rats injected with SP (10 and 100 pmol/0.2 lL) into the CeA or
BLA. It was also tested the efﬁcacy of SPA (10, 100 and 500 pmol/
0.2 lL) in the CeA. For the responses induced by ES of dPAG, the
rats received SPA (100 pmol/0.2 mL) into the CeA. Control animals
received the same volume of PBS in all experiments.
3.4. Microinjection procedure
Glass micropipettes were used for microinjections based on
previous studies from this laboratory (Nobre, Lopes, & Brandao,
2004; Santos, Macedo, & Brandao, 2008). Brieﬂy, micropipettes
were made of a fused silica capillary (o.d. 150 lm, i.d. 75 lm; Clu-
zeau Info Lab., France). To prevent cannulae breaks, the capillarywas ﬁxed in a device made with needles of 0.60  25 and
1.00  25 mm (Becton–Dickinson). The guide-cannulae were posi-
tioned 7.6 mm below the skull for BLA and 7.0 mm for CeA. Then,
the fused silica capillary protruded 1.0 mm beyond the guide-can-
nula to reach the CeA or BLA respectively. The micropipette was
linked to a 5-lL Hamilton syringe by means of polyethylene tubing
(PE-10; Becton–Dickinson, Franklin Lakes, NJ) connected to a micr-
oinfusion apparatus (Harvard, USA). A constant volume of 0.2 lL
was injected over 60 s. The displacement of an air bubble inside
the polyethylene tubing connecting the syringe needle to the glass
needle was used to monitor the microinjections. Following the end
of the injections, the microinjection pipettes were held inside the
brain for a further 60 s to maximize diffusion of the drug away
from the tip.
3.5. Histology
Upon completion of the experiments, the animals were over-
dosed with urethane (Sigma Aldrich) and perfused intracardially
with saline followed by buffered 4% formalin. In order to mark
the drug injection site at the end of each study, Evans Blue dye
(2%) was microinjected into the BLA or CeA (0.2 lL/min). The
brains were removed and maintained in formalin solution for
24 h and then kept in 30% sucrose solution for another three days.
Serial 60 lm brain sections were cut using a cryostat (Leica, Wetz-
lar, Germany), thaw-mounted on gelatinized slides and stained
with cresyl violet in order to localize the sites of injection with ref-
erence to Paxinos and Watson (2005).
3.6. Analysis of results
Data are expressed as mean ± SEM. For the EPM test, one-way
analysis of variance (ANOVA) was used to assess the effects of SP
into the CeA or BLA (experiment I). One-way ANOVA was also used
to analyze the effects of different doses of SPA in the CeA. For the
effects of SPA injections before administration of SP, comparisons
between groups were carried out using two-way ANOVA where
SP and SPA were considered the two main factors (PBS–PBS;
PBS–SP; SPA–PBS; SPA–SP) (experiment II). To assess the effects of
SPA injections into the CeA on the defensive responses induced
by ES of dPAG, the differences in the aversive thresholds for the
groups were subjected to a two way-ANOVA with repeated mea-
sures, using treatments (PBS or SPA) and defensive responses (freez-
ing and escape) as factors. The duration of PSF was analyzed with a
two-way ANOVA with repeated measures using treatments (SPA
and PBS) and conditions (pre- and post-injections) as factors (exper-
iment III). Fisher’s LSD post-hoc comparisons were performed when
signiﬁcant overall F-values were obtained in the ANOVA (p < 0.05).4. Results
The tips of the electrodes were located within the dorsal part of
the PAG and the injection sites in the amygdala were located inside
the CeA or BLA (Fig. 1)
4.1. Experiment I
Independent groups of rats injected with SP (10 and 100 pmol/
0.2 lL) into the CeA and BLA were submitted to the EPM test. In
relation to CeA, one-way ANOVA showed signiﬁcant differences
in the frequency of entries in the open arms (F2,21 = 3.04;
p < 0.05), in the percentages of time spent in the open and closed
arms/total (F2,21 = 5.92 and 7.11; p < 0.05, respectively). Post-hoc
comparisons revealed that both doses of SP reduced the frequency
of entries in the open arms as well as the percentage of time spent
Fig. 1. Representative photomicrographs of microinjections into the (A) central amygdalar nuclei, (B) basolateral and (C) the electrode tips in the dPAG. The black points
represent the sites of injections into the amygdalar nuclei and the electrode tips in the dPAG. Scale bars represent 500 lm in all photographs. The number of sites indicated in
the ﬁgures is less than the number of injected animals because of several overlaps. CeA: central nucleus of the amygdala, BLA: basolateral nucleus of the amygdala, dmPAG:
dorsomedial periaqueductal gray and dlPAG: dorsolateral periaqueductal gray.
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respectively). This analysis also revealed that both doses of SP in-
creased the percentage of time spent in the closed arms/total inFig. 2. Effects of substance P (SP – 10 and 100 pmol/0.2 mL) injected into the central (Ce
maze. Each bar represents mean + SEM of frequency of entries in the open and closed arm
total time (B and E, respectively), and % of entries in the open and closed arms compared
group. PBS (n = 9), SP 10 (n = 7) and SP 100 (n = 8) for CeA and PBS (n = 8), SP 10 (n = 7)relation to control group (Fig. 2E). However, one-way ANOVA re-
vealed no signiﬁcant differences in the frequency of closed arm en-
tries (F2,21 = 0.01; p > 0.05) nor in the percentages of frequency ofA) and basolateral (BLA) nuclei of the amygdala on rat behavior in the elevated plus
s (A and D, respectively), % of time spent in the open and closed arms compared with
with total entries (C and F, respectively). p < 0.05 compared with respective control
and SP 100 (n = 7) for BLA.
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p > 0.05, respectively) (Fig. 2D, C and F, respectively). In relation
to BLA, the statistical analysis showed no signiﬁcant differences
in the measures evaluated in the EPM test (frequency of entries
in the open and closed arms [F2,19 = 0.86 and 1.09; p > 0.05, respec-
tively], in the percentages of time spent in the open and closed
arms/total [F2,19 = 0.20 and 0.57; p > 0.05, respectively] and in the
percentages of frequency of entries in the open and closed arms/to-
tal [F2,19 = 0.41 and 0.41; p > 0.05, respectively]) (Fig. 2A–F).4.2. Experiment II
As for SP, experiments using different groups of rats were in-
jected with different doses of SPA (10, 100 and 500 pmol/0.2 lL)
into the CeA and submitted to the EPM test. One-way ANOVA
showed no signiﬁcant differences between the doses in relation
to the number of entries in the open arms (F3,27 = 2.64; p > 0.05)
nor in the percentage of frequency of entries and time spent in
the open arms/total (F3,27 = 2,71 and 2,49; p > 0.05, respectively).
However, the analysis showed signiﬁcant differences in relation
to the number of entries into the closed arms (F3,27 = 3.89;
p < 0.05), but the only signiﬁcant between-groups differences were
found in the comparison between SPA 500 and SPA 10 – treated
groups (Fisher’s LSD post-hoc test). However, an important ﬁnding
in these studies is that SPA alone produced no effects compared to
controls (Fig. 3A and B).
The frequencies of entries in the open and closed arms and the
percentage of entries and time spent in the open arms/total in the
EPM test by rats treated with PBS or SPA (100 pmol/0.2 lL) in com-
bination with PBS or SP (100 pmol/0.2 lL) injected into the CeA are
shown in Fig. 4A and B, respectively. Two-way ANOVA followed by
Fisher’s LSD post-hoc test showed a signiﬁcant reduction in the
number of entries in the open arms of the EPM in the PBS–SP group
in relation to PBS–PBS (F1,32 = 4.53, p < 0.05). However, no signiﬁ-
cant differences were observed in the open arms entries after
SPA treatment [SPA–PBS and SPA–SP (F1,32 = 0.08, p > 0.05)] nor
was there any interaction between them (F1,32 = 3.73, p > 0.05). In
relation to the number of entries in the closed arms of the EPM,
the analysis showed no differences between treatments [PBS–PBS
and PBS–SP (F1,32 = 0.03); SPA–PBS and SPA–SP (F1,32 = 0.37) nor
any interaction between them (F1,32 = 0.06), p > 0.05 for all cases].
The two-way ANOVA also showed no differences between
groups in relation to the percentage of time spent in the open
arms/total [PBS–PBS and PBS–SP (F1,32 = 3.27) and SPA–PBS and
SPA–SP (F1,32 = 0.34); p > 0.05). However, there was an interaction
between them (F1,32 = 6.65, p < 0.05). Post-hoc comparisons re-
vealed that SP injections into the CeA reduced the percentage of
time in the open arms/total of the EPM in relation to the control
group and that the effect was reversed by SPA injections. In rela-
tion to the percentage of frequency of entries in the open arms/to-
tal, the analysis also showed no differences between treatmentsFig. 3. Effects of spantide (SPA – 10, 100 and 500 pmol/0.2 mL) injected into the central
represents mean + SEM of number of entries in the open and closed arms (A) and percen
SPA 100 (n = 8) and SPA 500 (n = 8).[PBS–PBS and PBS–SP (F1,32 = 4.10); SPA–PBS and SPA–SP
(F1,32 = 0.01); nor any interaction between them (F1,32 = 2.18),
p > 0.05 for all cases].
4.3. Experiment III
Fig. 5A shows the difference (D) in the freezing and escape
thresholds in response to ES of the dPAG before and after treat-
ment with PBS or SPA (100 pmol/0.2 lL) into the CeA. Two-way
ANOVA with repeated measures showed no signiﬁcant differences
between treatments (F1,19 = 0.01; p > 0.05). A lack of signiﬁcant ef-
fects was also observed in freezing and escape responses
(F1,19 = 0.60; p > 0.05). Likewise, the interaction between treat-
ments versus defensive responses was not statistically different
(F1,19 = 0.60; p > 0.05).
Two-way ANOVA with repeated measures was also performed
on the duration of PSF behavior, when the ES of dPAG at escape
threshold had ceased (Fig. 5B). The analysis showed signiﬁcant dif-
ferences between conditions (F1,19 = 11.22; p < 0.05), but not be-
tween treatments (F1,19 = 1.40; p > 0.05). However, there was an
interaction between them (F1,19 = 22.36; p < 0.05). Post-hoc com-
parisons indicated that intra-CeA SPA injections signiﬁcantly re-
duced the time of PSF when compared to the pre-injection
condition. Additionally, it was also different from the PBS group.5. Discussion
The present results showed that SP injected into the CeA, but
not into the BLA, evoked anxiogenic-like effects in the EPM and
they may be linked to NK1 receptors. In addition, blockade of
NK1 receptors into the CeA reduced the time of post-escape freez-
ing evoked by ES of dPAG, but did not change the aversive thresh-
olds for freezing and escape. Interestingly, the SP system did not
appear to be tonically active since administration of SPA per se
had no effect on behavior in the EPM.
Although studies have failed to provide evidence for an involve-
ment of SP in the CeA in behavioral responses related to fear and
anxiety using behavioral models such as immobilization stress
and conditioned fear responses (Ebner et al., 2004; Zhao et al.,
2009), the present ﬁndings suggest that SP in the CeA, an output
of the amygdalar complex, is a mediator of the aversiveness asso-
ciated with the open space and height of the EPM represents to the
animal (Pellow et al., 1985). This could be the reason for why the
SP injections into the CeA have improved the performance of rats
in animal models related to associative aversive learning (Kertes,
Laszlo, Berta, & Lenard, 2009a, 2009b). The anxiogenic-like effects
of SP in the CeA were not due to motor alterations since the treat-
ment did not change the number of entries in the closed arms of
the EPM. However, the fact that rats spent more time in the closed
arms of the apparatus than control group strengthens our proposal
that SP has an anxiogenic proﬁle in this nucleus of the amygdala.nucleus of the amygdala (CeA) on rat behavior in the elevated plus maze. Each bar
tage of entries and time spent in the open arms/total (B). PBS (n = 7), SPA 10 (n = 8),
Fig. 4. Effect of spantide (SPA – 100 pmol/0.2 mL) injected into the central nucleus of the amygdala (CeA) on rat behavior in the elevated plus maze. The animals received PBS
or SPA into the CeA. After 5 min, they received intra-CeA microinjection of PBS or substance P (SP – 100 pmol/0.2 mL). Each bar represents mean + SEM of number of entries in
the open and closed arms (A) and percentage of entries and time spent in the open arms/ total (B). p < 0.05 compared with control group and #p < 0.05 compared with PBS–
SP. PBS–PBS (n = 12), PBS–SP (n = 9), SPA–PBS (n = 7) and SPA–SP (n = 8).
Fig. 5. Effect of spantide (SPA – 100 pmol/0.2 mL) injected into the central nucleus
of the amygdala (CeA) on defensive behaviors elicited by electrical stimulation of
dorsal periaqueductal gray. Differences (D) in thresholds of freezing and escape
responses determined after PBS or SPA injections into the CeA (A) and duration (s)
of post-stimulation freezing before and after of PBS or SPA injections into the CeA
(B). p < 0.05 in relation to pre-injection; #p < 0.05 in relation to PBS. PBS (n = 12)
and SPA (n = 9).
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ulate the defense mechanisms of the CeA only when they are called
into play by the presence of aversive stimuli, i.e., this mediation is
phasic. SP may mimic the effects of anxiogenic stimuli and activate
these neural mechanisms, but NK1 antagonists do not produce any
effect by their own. Therefore SP and NK1 receptors activation may
be phasically involved in very speciﬁc aspects of fear and anxiety
behaviors.
Also in the BLA, the role of SP seems to be situation speciﬁc. For
example, downregulation of NK1 receptors in the BLA has been re-
ported during maternal separation and immobilization stress, per-
haps reﬂecting a response to increased release of SP in the synaptic
cleft (Boyce et al., 2001; Smith et al., 1999). In the fear potentiated
startle paradigm, the blockade of NK1 of the BLA inhibited the
expression of this conditioned fear response (Zhao et al., 2009).
In contrast, the present results using the EPM showed that the
administration of different doses of SP in the BLA had no effect.
The kind of aversion elicited in these different models may be rel-
evant to these ﬁndings. In the EPM, unlike immobilization stress
and fear potentiated startle, the animals have the choice to avoid
the aversive environment. The aversive stimulus is an extentavoidable. It may be that SP and NK1 receptors of the BLA do not
participate in this type of decision-making.
The unconditioned fear of height and open spaces produced by
the EPM is completely different from the one elicited by the ES of
dPAG. The latter is characterized by undirected and explosive ﬂight
reactions and it has been proposed as a model of panic attacks
(Graeff, 1990; Lovick, 2000; Schenberg et al., 2001). The freezing
produced during the ES of the dPAG is a preparatory response for
the escape reaction to an imminent danger. The freezing and es-
cape responses evoked by the ES of dPAG immediately activates di-
rect projections from the dPAG to other brainstem structures
including some more caudal as the cuneiform nucleus (Vianna,
Borelli, Ferreira-Netto, Macedo, & Brandao, 2003). However, the
dPAG-PSF, which is elicited once the ﬂight reaction has ceased, is
thought to reﬂect the processing as well as the transference of
the information coupled to that kind of aversive experience to
prosencephalic structures, including the amygdala and may con-
tribute to an associative learning process which will aid future
identiﬁcation of previously experienced aversive stimuli (Brandao
et al., 2008). This assumption is in agreement with previous studies
which showed that electrical lesions or inactivation of the CeA
with muscimol, a GABA-A agonist, did not inﬂuence the expression
of the preparatory freezing for ﬂight, but reduced the dPAG-PSF
(Martinez et al., 2006; Oliveira, Nobre, Brandao, & Landeira-Fer-
nandez, 2004). Although the contextual conditioned freezing and
the dPAG post-stimulation freezing are both reduced by inactiva-
tion of the amygdala, evidence indicating that they have distinct
functional meaning has been provided recently (see Brandao
et al., 2008, for a review). The context-conditioned freezing medi-
ated by amygdala – ventral PAG circuit decreases with termination
of the stimulation, whereas the dPAG-evoked post-stimulation
freezing persists at high levels after the stimulation and is not con-
text dependent: that is, when these animals are submitted to the
context shift procedure after dPAG stimulation, this kind of freez-
ing does not disappear (Vianna et al., 2001a, 2001b, 2003). Thus,
the amygdala can affect some, but not all, aspects of unconditioned
freezing. With great probability to reach the amygdala this ac-
quired and ascending information is probably relayed through
the dorsolateral nucleus of the thalamus (Ferreira-Netto, Borelli,
& Brandao, 2005). The dPAG-evoked post-stimulation freezing pro-
cedure has some similarities with the defensive behaviors ob-
served after prey- predator encounter. In support of this,
defensive immobility has been reported following explosive escape
in mice placed in a confrontation with a snake model to study
panic-like reactions (Uribe-Marino et al., 2012). In fact, these mod-
els have developed from previous observations on the usefulness of
the models associated to predator (rats)-elicited ﬂight responses in
mice for the investigation of panic-modulating drugs (Blanchard,
Griebel, & Blanchard, 2003; Blanchard, Yudko, Rodgers, & Blan-
chard, 1993). Working on this model we found in the present study
that the blockade of the NK1 receptors of the CeA did not change
the aversive thresholds for freezing and escape, but it reduced
26 M.C. Carvalho et al. / Neurobiology of Learning and Memory 102 (2013) 20–27signiﬁcantly the duration of dPAG-PSF. These ﬁndings suggest that
NK1 receptors mediate the processing of the aversive stimuli that
ascend from the dPAG. Thus, the reduction of the duration of
dPAG-PSF after intra-CeA administration of SPA in the present
experiments could lead to impairment in the processing of aversive
information that ascends to the amygdala (Brenes, Broiz, Bassi,
Schwarting, & Brandao, 2012).
In summary, the present study highlights that SP may be in-
volved in mediating responses of the animal in only certain types
of defensive behavior and suggests a differential participation of
the NK1 receptors in the processing of distinct types of fear in
the amygdala. The EPM gives the animal some control over its
environment i.e. the option to choose or not to enter the open
arm and dPAG-PSF is thought to reﬂect a period when the animal
evaluates the signiﬁcance of dPAG-evoked aversion once the
unconditioned responses of freezing and escape were elicited.
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